Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Mexico intravenous solution market was valued at USD 626.22 Million in 2025 and is expected to grow at a CAGR of 6.80%, reaching USD 1209.04 Million by 2035. The market is supported by increasing access to healthcare facilities, rising cases of dehydration and chronic diseases, and growing awareness of intravenous therapy. Government investments in public health and the introduction of affordable generic IV solutions are projected to enhance growth. Expansion of private hospitals and medical tourism further strengthens market performance.
Base Year
Historical Period
Forecast Period
The market is witnessing significant growth driven by the increasing prevalence of chronic diseases, a rise in surgical interventions, and the growing demand for home-based healthcare solutions.
Several key trends in the market include adoption of ready-to-use intravenous solutions, integration of smart infusion technologies, and increased utilization of parenteral nutrition, which are contributing to improved clinical efficiency and market expansion.
Leading players in the market are accelerating growth through continuous innovation in formulations, expansion of distribution channels, and enhancement of local manufacturing capabilities to meet rising demand and ensure regulatory compliance.
Compound Annual Growth Rate
6.8%
Value in USD Million
2026-2035
*this image is indicative*
Intravenous (IV) solutions serve a critical role in ensuring effective fluid therapy, nutritional support, and pharmaceutical delivery across healthcare systems. The market in Mexico is fueled by improving access to healthcare services, growth in public hospital investments, and a rising number of surgical procedures. The increasing burden of chronic and infectious diseases also contributes to the sustained demand for IV therapies. Moreover, government initiatives aimed at modernizing healthcare infrastructure are supporting further development. The market is poised to reach USD 1209.04 Million by 2035.
Rising Cardiovascular Cases to Drive Market Demand
The increasing burden of cardiovascular diseases, which frequently require intensive care and fluid management through IV therapies, is a significant growth driver. In March 2024, the National Institute of Statistics and Geography reported that heart diseases remained the leading cause of death in 2023, with over 97,000 recorded fatalities across the country. This alarming health trend underscores the growing demand for intravenous solutions in critical care settings. The continued rise in such conditions is expected to fuel steady market expansion in the coming years.
Some of the trends in the market include the expansion of functional hydration products and the growing aging population.
Expansion of Functional Hydration Products to Boost Mexico Intravenous Solution Market Growth
The market is witnessing an increasing integration of functional hydration solutions into consumer health. For instance, in May 2024, Unilever expanded the presence of its leading brand, Liquid I.V., into Mexico as part of its global growth strategy. Known for its science-backed hydration formulas combining electrolytes, vitamins, and nutrients, Liquid I.V. is addressing the increasing demand for convenient and effective hydration. This strategic move is expected to enhance innovation and product accessibility, thereby accelerating market value and supporting long-term industry growth in Mexico.
Aging Population is Expected to Enhance Mexico Intravenous Solution Market Demand
The increasing elderly population in Mexico is emerging as a significant driver in the intravenous (IV) solution market. As the country experiences a rapid demographic shift toward an aging society, the demand for IV therapies is rising due to age-related health conditions and chronic diseases. Americas Quarterly highlighted that by 2100, over 31% of Latin America's population, including Mexico, will be aged 65 and above. This demographic evolution is expected to significantly enhance market growth in the coming years.
Amino Acids to Lead the Market Segmentation Based on Nutrients
The market includes a range of vital nutrient segments, comprising carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids. Among them, the amino acids segment is expected to lead the market in the coming years. This dominance is driven by the increasing demand for amino acid-based intravenous solutions in parenteral nutrition, especially for patients unable to consume adequate protein orally or enterally due to surgery, trauma, or chronic illness.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Ajinomoto supplies multi-compendial amino acids and specialty ingredients used in parenteral nutrition and intravenous pharmaceutical formulations. In Mexico the company supports IV therapy indirectly by providing high-purity amino acids and excipients to pharmaceutical manufacturers and hospital-nutrition suppliers, and by maintaining cGMP manufacturing and regulatory-compliant documentation that facilitate use in compounding and finished IV products. Their focus is on ingredient quality, regulatory support and partnerships with regional formulators.
B. Braun engages the Mexican IV space through its global infusion-therapy portfolio, regional distribution and country presence, offering IV fluids, infusion sets, pumps and clinical services tailored for hospital workflows. The company combines products (solutions, automated infusion systems) with training and supply-chain support to Mexican hospitals and distributors, positioning itself as a partner for safer, more efficient IV therapy across acute and ambulatory settings.
ICU Medical serves Mexico with a full infusion-therapy offering — IV solutions, administration sets, pumps and accessory products — supported by a Mexico contact and Latin America service resources. The company also assembles and configures certain infusion systems and oncology/ancillary kits in Mexican facilities and coordinates local distribution and clinical service materials (manuals, technical support) to ensure safe delivery of IV fluids and medications in Mexican hospitals and clinics.
Baxter has a long operational footprint in Mexico that includes manufacturing sites producing intravenous solutions, parenteral nutrition components and related administration devices. The company supplies IV fluids and irrigation products into the Mexican market and has used its Mexico manufacturing capacity to support regional supply and temporary international importation programs when needed, coupling local production with hospital customer training and distribution networks.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Fresenius Kabi AG, Pfizer Inc., Otsuka Pharmaceutical Co., Ltd., and Vifor Pharma Management Ltd.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Nutrients
Market Breakup by Bag Type
Market Breakup by Application
Market Breakup by End User
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Nutrients |
|
| Breakup by Bag Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share